Assessing glycaemic variability with continuous glucose monitoring system before and after continuous subcutaneous insulin infusion in people with Type 1 diabetes

被引：7
|
作者：
Moya Chimenti, Elisa [1 ]
Herranz de la Morena, Lucrecia [2 ]
Martin Vaquero, Pilar [2 ]
Saez-de-ibarra, Lourdes [2 ]
Garcia Dominguez, Maria [3 ]
Pallardo Sanchez, Luis Felipe [2 ]
机构：
[1] Hosp Infanta Cristina, Dept Endocrinol, Madrid 28981, Spain
[2] La Paz Univ Hosp, Dept Endocrinol, Madrid 28046, Spain
[3] Hosp Sureste, Dept Endocrinol, Madrid 28500, Spain
来源：
DIABETES RESEARCH AND CLINICAL PRACTICE | 2010年 / 90卷 / 03期
关键词：
Continuous subcutaneous insulin infusion (CSII); Diabetes mellitus Type 1 (T1DM); Glycaemic control; PUMP THERAPY; CHILDREN; MELLITUS;
D O I：
10.1016/j.diabres.2010.08.016
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
We evaluated glycaemic variability with continuous glucose monitoring system in 31 people with Type 1 diabetes mellitus using multiple daily injections initially and after switching to continuous subcutaneous insulin infusion. There was a significant improvement in HbA1c, mean glucose, standard deviation of mean glucose and in hyperglycaemic excursions with CSII. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码：E57 / E59
页数：3
相关论文
共 50 条
  • [1] Cutaneous Reactions to Continuous Glucose Monitoring and Continuous Subcutaneous Insulin Infusion Devices in Type 1 Diabetes
    Severin, Rachel K.
    Gandica, Rachelle
    Levin, Laura E.
    Belsito, Donald V.
    Garzon, Maria C.
    Williams, Kristen M.
    DIABETES, 2018, 67
  • [2] Continuous subcutaneous insulin infusion alters microRNA expression and glycaemic variability in children with type 1 diabetes
    Emma S. Scott
    Andrzej S. Januszewski
    Luke M. Carroll
    Gregory R. Fulcher
    Mugdha V. Joglekar
    Anandwardhan A. Hardikar
    Timothy W. Jones
    Elizabeth A. Davis
    Alicia J. Jenkins
    Scientific Reports, 11
  • [3] Continuous subcutaneous insulin infusion alters microRNA expression and glycaemic variability in children with type 1 diabetes
    Scott, Emma S.
    Januszewski, Andrzej S.
    Carroll, Luke M.
    Fulcher, Gregory R.
    Joglekar, Mugdha V.
    Hardikar, Anandwardhan A.
    Jones, Timothy W.
    Davis, Elizabeth A.
    Jenkins, Alicia J.
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [4] Continuous glucose monitoring in type 1 diabetic patients with continuous subcutaneous insulin infusion
    Alves, Marta
    Neves, Celestino
    Varela, Ana
    Arteiro, Cristina
    Pereira, Luis M.
    Carvaiho, Davide
    Medina, Jose L.
    DIABETES, 2008, 57 : A547 - A547
  • [5] Cutaneous Reactions to Continuous Glucose Monitoring and Continuous Subcutaneous Insulin Infusion Devices in Type 1 Diabetes Mellitus
    Rigo, Rachel S.
    Levin, Laura E.
    Belsito, Donald V.
    Garzon, Maria C.
    Gandica, Rachelle
    Williams, Kristen M.
    JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY, 2021, 15 (04): : 786 - 791
  • [6] Continuous Subcutaneous Insulin Infusion from Diagnosis of Type 1 Diabetes Improves Intermediate Glycaemic Variability in Children
    Scott, Emma S.
    Januszewski, Andrzej S.
    Fulcher, Greg
    Jones, Timothy
    Davis, Elizabeth A.
    Jenkins, Alicia J.
    DIABETES, 2019, 68
  • [7] Variability in Basal Insulin Needs in Young Patients with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion and Continuous Glucose Monitoring with Predictive Low Glucose Insulin Suspension
    De Tezanos-Pinto, A.
    Pichott, M.
    Barra, A.
    Avila, A.
    Cassorla, F.
    Codner, E.
    Gaete, X.
    Mericq, V
    Roman, R.
    HORMONE RESEARCH IN PAEDIATRICS, 2019, 92 : 21 - 22
  • [8] Diabetes technologies in people with type 1 diabetes mellitus and disordered eating: A systematic review on continuous subcutaneous insulin infusion, continuous glucose monitoring and automated insulin delivery
    Priesterroth, Lilli
    Grammes, Jennifer
    Clauter, Mona
    Kubiak, Thomas
    DIABETIC MEDICINE, 2021, 38 (07)
  • [9] Glycaemic profile by continuous glucose monitoring system in a cohort of adolescents treated with continuous subcutaneous insulin infusion or long acting insulin analogues
    Anzellotti, M.
    Di Stefano, A.
    Carinci, S.
    Chiarelli, F.
    Tumini, S.
    DIABETOLOGIA, 2008, 51 : S438 - S438
  • [10] Impact of technology on glycaemic control in type 2 diabetes: A meta-analysis of randomized trials on continuous glucose monitoring and continuous subcutaneous insulin infusion
    Dicembrini, Ilaria
    Mannucci, Edoardo
    Monami, Matteo
    Pala, Laura
    DIABETES OBESITY & METABOLISM, 2019, 21 (12): : 2619 - 2625
12345